-
5 days ago | 
dermatologytimes.com | Brian Nowosielski
Researchers discovered a notable correlation between atopic dermatitis and dementia, according to data published in Acta Dermato-Venereologica.1 Despite randomization analysis failing to identify a causal relationship between the 2 conditions, study results were able to inform future exploration into this correlation.
-
1 week ago | 
drugtopics.com | Brian Nowosielski |Marta Wosinska |Joey Mattingly
While not yet imposed—and with great uncertainty regarding widespread implementation—many pharmacy industry experts are scrambling to understand the true impact of pharmaceutical tariffs should they be enacted. However, until they are widespread across the country, experts are urging pharmacies to advocate against these tariffs while also preparing for their implementation.
-
1 week ago | 
drugtopics.com | Brian Nowosielski |Marta Wosinska |Joey Mattingly
When it comes to the US imposing tariffs within any sector of American business, there are specific entities that will be forced to absorb costs and essentially lose money. In the case of pharmaceuticals, tariffs could cause immense jumps in drug prices, in turn, creating a greater challenge for pharmacies to stay financially sustainable and keep their necessary inventory in optimal supply. “If there's a tariff, somebody is going to have to absorb it.
-
1 week ago | 
drugtopics.com | Brian Nowosielski
CVS Health and Express Scripts filed lawsuits Thursday in an attempt to overturn Arkansas Act 624, which bans pharmacy benefit managers (PBMs) from owning a pharmacy business in the state.1,2 The companies claimed the law poses an unconstitutional restriction on interstate commerce because it burdens those that operate outside of Arkansas.
-
1 week ago | 
drugtopics.com | Brian Nowosielski |David Swenson
CCT Rx Shortage Solutions is a simple yet useful way for pharmacies to identify drug shortages in real time. The new technology—developed by Cold Chain Technologies and ShortStop Rx—is helping pharmacists stay on top of prescription drug updates and ensuring patients have access to their pharmacy’s medications. “We thought, we need to help pharmacies.
-
1 week ago | 
drugtopics.com | Brian Nowosielski |Alecia Lashier
With the help of technology and digital innovation, the pharmacy industry has rapidly evolved in the past 25 years. Moving away from manual processes and paper-driven workflows, the role of the pharmacist—and nearly every entity within the supply chain—is shifting in real time. “The first movement, when I started here at iA, was how do we increase the quality and efficiency of the prescription fulfillment process?” said Alecia Lashier, chief automation officer and executive vice president at iA.
-
1 week ago | 
drugtopics.com | Brian Nowosielski
The US Department of Health & Human Services (HHS) has canceled $590 million in funding with Moderna that was supporting the development of an investigational pandemic influenza vaccine to protect against bird flu, the biotechnology company said in a release.1 Moderna also announced positive results from its phase 1/2 clinical trial of the vaccine, which showed a rapid and durable immune response among nearly 300 adults patients.
-
1 week ago | 
drugtopics.com | Brian Nowosielski
Investigation and reform for pharmacy benefit manager (PBM) reimbursement practices in Medicare Part D plans is necessary to ensure beneficiaries’ access to generic drugs, according to a study published in JAMA Health Forum.1 Researchers identified large markups that beneficiaries were responsible for paying, highlighting results of the study that support the need for policy changes. “Generic drugs represent 90% of prescriptions filled in the US,” wrote the authors.
-
1 week ago | 
drugtopics.com | Brian Nowosielski
With the introduction of conversational artificial intelligence agents (CAIAs), these emerging technologies are still at the beginning stages of adoption in pharmacy education and the profession as a whole.
-
1 week ago | 
drugtopics.com | Brian Nowosielski
The use of social norms, messenger effects, and processing fluency in communication failed to improve adherence for the use of hypertension medication, according to data published in JAMA Network Open.1 With little success in the use of behavioral science methods, researchers believe more evidence is necessary to identify alternative approaches in boosting adherence.
